Patient selection for immunotherapy in head and neck cancer

Volume: 22, Issue: 7, Pages: e290 - e290
Published: Jul 1, 2021
Abstract
Nancy Y Lee and colleagues 1 Lee NY Ferris RL Psyrri A et al. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol. 2021; 22: 450-462 Summary Full Text Full Text PDF PubMed Scopus (59) Google Scholar should be congratulated for their efforts in...
Paper Details
Title
Patient selection for immunotherapy in head and neck cancer
Published Date
Jul 1, 2021
Volume
22
Issue
7
Pages
e290 - e290
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.